NewslettersImmune Regulation News KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer By Danielle Corrigan - June 24, 2022 0 Scientists demonstrated that a lysine 4 histone H3 demethylase (KDM5A) impaired epithelial ovarian cancer infiltration by immune cells and inhibited antitumor immune responses. [Cancer Immunology Research] Abstract